Cynata Therapeutics Ltd
ASX:CYP
Cynata Therapeutics Ltd
ASX:CYP
Price:
0.33
AUD
3.13%
Market Closed
Market Cap:
AU$78.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cynata Therapeutics Ltd
ASX:CYP
|
AU |
|
Ikwezi Mining Ltd
ASX:IKW
|
BM |
|
D
|
Duty Free International Ltd
SGX:5SO
|
SG |
|
Patriot National Bancorp Inc
NASDAQ:PNBK
|
US |
|
Pilgrims Pride Corp
NASDAQ:PPC
|
US |
|
S
|
SBI Investment Korea Co Ltd
KOSDAQ:019550
|
KR |
|
Universal Health Realty Income Trust
NYSE:UHT
|
US |
|
V
|
VIP Gloves Ltd
ASX:VIP
|
MY |
|
Companhia de Saneamento Basico do Estado de Sao Paulo SABESP
NYSE:SBS
|
BR |
|
Ceapro Inc
XTSX:CZO
|
CA |
|
Ribbon Communications Inc
NASDAQ:RBBN
|
US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CYP's stock price target?
Not Available
CYP doesn't have any price targets made by Wall Street professionals.
What is Cynata Therapeutics Ltd's Revenue forecast?
Projected CAGR
123%
123%
For the last 13 years the
compound annual growth rate for
Cynata Therapeutics Ltd's revenue is
-3%.
The projected
CAGR
for the next 3 years is
123%.
